Kim A. Tran

Kim A. Tran

Auto-generated profile, based on publicly available information

Kim A. Tran

Department of Medicine, Meakins-Christie Laboratories, Research Institute McGill University Health Centre, McGill University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
KTKim A. Tran
Kim A. Tran
EPErwan Pernet
Erwan Pernet
MSMina Sadeghi
Mina Sadeghi
JDJeffrey Downey
Jeffrey Downey
JCJulia Chronopoulos
Julia Chronopoulos
MDMaziar Divangahi
Maziar Divangahi

21 February 2022 in Cell Reports
Verified
Journal Article
Open access
EKEva Kaufmann
Eva Kaufmann
NKNargis Khan
Nargis Khan
KTKim A. Tran
Kim A. Tran
AUAntigona Ulndreaj
Antigona Ulndreaj
EPErwan Pernet
Erwan Pernet
MDMaziar Divangahi
Maziar Divangahi
Since the vast majority of species solely rely on innate immunity for host defense, it stands to reason that a critical evolutionary trait like immunological memory evolved in this primitive branch of our immune system. There is ample evidence that vaccines such as bacillus Calmette-Guérin (BCG) induce protective innate immune memory responses (trained immunity) against heterologous pathogens. Here we show that while BCG vaccination significantly reduces morbidity and mortality against influenza A virus (IAV), it fails to provide protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In contrast to IAV, SARS-CoV-2 infection leads to unique pulmonary vasculature damage facilitating viral dissemination to other organs, including the bone marrow (BM), a central site for BCG-mediated trained immunity. Finally, monocytes from BCG-vaccinated individuals mount an efficient cytokine response to IAV infection, while this response is minimal following SARS-CoV-2. Collectively, our data suggest that the protective capacity of BCG vaccination is contingent on viral pathogenesis and tissue tropism.

4 January 2023 in Nature
Verified
Journal Article
Open access
PDF file
EPErwan Pernet
Erwan Pernet
SSSarah Sun
Sarah Sun
NSNicole Sarden
Nicole Sarden
SGSaideep Gona
Saideep Gona
ANAngela Nguyen
Angela Nguyen
MDMaziar Divangahi
Maziar Divangahi
Resident-tissue macrophages (RTMs) arise from embryonic precursors1,2, yet the developmental signals that shape their longevity remain largely unknown. Here we demonstrate in mice genetically deficient in 12-lipoxygenase and 15-lipoxygenase (Alox15−/− mice) that neonatal neutrophil-derived 12-HETE is required for self-renewal and maintenance of alveolar macrophages (AMs) during lung development. Although the seeding and differentiation of AM progenitors remained intact, the absence of 12-HETE led to a significant reduction in AMs in adult lungs and enhanced senescence owing to increased prostaglandin E2 production. A compromised AM compartment resulted in increased susceptibility to acute lung injury induced by lipopolysaccharide and to pulmonary infections with influenza A virus or SARS-CoV-2. Our results highlight the complexity of prenatal RTM programming and reveal their dependency on in trans eicosanoid production by neutrophils for lifelong self-renewal.

8 January 2025 in Nature Immunology
Verified
Journal Article
Open access
PDF file
NKNargis Khan
Nargis Khan
KTKim A. Tran
Kim A. Tran
RCRaphael Chevre
Raphael Chevre
VLVeronica Locher
Veronica Locher
MRMathis Richter
Mathis Richter
MDMaziar Divangahi
Maziar Divangahi
Disease tolerance is an evolutionarily conserved host defense strategy that preserves tissue integrity and physiology without affecting pathogen load. Unlike host resistance, the mechanisms underlying disease tolerance remain poorly understood. In the present study, we investigated whether an adjuvant (β-glucan) can reprogram innate immunity to provide protection against influenza A virus (IAV) infection. β-Glucan treatment reduces the morbidity and mortality against IAV infection, independent of host resistance. The enhanced survival is the result of increased recruitment of neutrophils via RoRγt+ T cells in the lung tissue. β-Glucan treatment promotes granulopoiesis in a type 1 interferon-dependent manner that leads to the generation of a unique subset of immature neutrophils utilizing a mitochondrial oxidative metabolism and producing interleukin-10. Collectively, our data indicate that β-glucan reprograms hematopoietic stem cells to generate neutrophils with a new ‘regulatory’ function, which is required for promoting disease tolerance and maintaining lung tissue integrity against viral infection.

2 July 2024 in Circulation
Verified
Journal Article
Closed access
PDF file
JGJana Grune
Jana Grune
GBGeetika Bajpai
Geetika Bajpai
POPervin Tülin Ocak
Pervin Tülin Ocak
EKEva Kaufmann
Eva Kaufmann
KMKyle Mentkowski
Kyle Mentkowski
MNMatthias Nahrendorf
Matthias Nahrendorf
BACKGROUND: Viral infections can cause acute respiratory distress syndrome (ARDS), systemic inflammation, and secondary cardiovascular complications. Lung macrophage subsets change during ARDS, but the role of heart macrophages in cardiac injury during viral ARDS remains unknown. Here we investigate how immune signals typical for viral ARDS affect cardiac macrophage subsets, cardiovascular health, and systemic inflammation. METHODS: We assessed cardiac macrophage subsets using immunofluorescence histology of autopsy specimens from 21 patients with COVID-19 with SARS-CoV-2–associated ARDS and 33 patients who died from other causes. In mice, we compared cardiac immune cell dynamics after SARS-CoV-2 infection with ARDS induced by intratracheal instillation of Toll-like receptor ligands and an ACE2 (angiotensin-converting enzyme 2) inhibitor. RESULTS: In humans, SARS-CoV-2 increased total cardiac macrophage counts and led to a higher proportion of CCR2 + (C-C chemokine receptor type 2 positive) macrophages. In mice, SARS-CoV-2 and virus-free lung injury triggered profound remodeling of cardiac resident macrophages, recapitulating the clinical expansion of CCR2 + macrophages. Treating mice exposed to virus-like ARDS with a tumor necrosis factor α–neutralizing antibody reduced cardiac monocytes and inflammatory MHCII lo CCR2 + macrophages while also preserving cardiac function. Virus-like ARDS elevated mortality in mice with pre-existing heart failure. CONCLUSIONS: Our data suggest that viral ARDS promotes cardiac inflammation by expanding the CCR2 + macrophage subset, and the associated cardiac phenotypes in mice can be elicited by activating the host immune system even without viral presence in the heart.

27 September 2024 in Science Advances
Verified
Journal Article
Open access
JCJulia Chronopoulos
Julia Chronopoulos
EPErwan Pernet
Erwan Pernet
KTKim A. Tran
Kim A. Tran
TMToby K. McGovern
Toby K. McGovern
AMArina Morozan
Arina Morozan
JMJames G. Martin
James G. Martin
Pregnancy is associated with profound changes in immunity. However, pregnancy-related respiratory immune adaptations in response to influenza infection and their impact on disease severity remain unclear. Here, we describe, in a preclinical model of mid-gestation pregnancy, a mechanism of enhanced host defense against influenza A virus (IAV) localized to the nasal cavity that limits viral replication and reduces the magnitude of intrapulmonary immune responses. Consequently, the pregnant mice show reduced pulmonary pathology and preserved airway function after IAV infection. The early restriction of viral replication is independent of type I interferon (IFN) but dependent on increased antimicrobial peptides (AMPs) driven by interleukin-17 + (IL-17 + ) γδ + T cells within the nasal passages. This pathway of host defense against IAV infection in the upper airways during pregnancy restricts early viral infection and prevents virus dissemination into the lung supporting maternal fitness.